Lumansag, Zevi .

HRN: 28-56-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/10/2026
02/17/2026
IV DRIP
140mg
Q6
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines